Home › NDC Lookup › Ingredients › Triamcinolone Acetonide › 11822-0443-01
👃image loading
(from DailyMed)

Nasal Allergy Triamcinolone acetonide 55 ug Spray, Metered — NDC 11822-0443-1 (Billing 11822-0443-01)

by Rite Aid Corporation · 1 BOTTLE in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE

This is a package of Nasal Allergy Triamcinolone acetonide 55 ug Spray, Metered from Rite Aid Corporation, no longer marketed (first marketed Jun 2017), no longer in the FDA NDC Directory, this package's marketing ended Aug 2026. It is this product's only package size.

NDC 11822-0443-01
🏷️ FDA NDC (as labeled) 11822-0443-1 billing pads the package segment with a zero
OTC Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Triamcinolone Acetonide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 28, 2023 — Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. (Eugia US LLC) · FDA recall D-0041-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Aug 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 11822-0443-1
Product NDC 11822-0443
11-digit billing NDC 11822044301
RxCUI 1797913
UNII F446C597KA
Application # ANDA078104
SPL Set ID b4136b1f-0618-42f0-a9e6-28a1852a909a
Established class (EPC) Corticosteroid
Mechanism of action Corticosteroid Hormone Receptor Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Aug 2026)
Marketing start 2017-06-15
Marketing end 2026-08-01
Route NASAL
Dosage form SPRAY, METERED
Substance TRIAMCINOLONE ACETONIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 96201020202070
GPI class RA Ethyl Rubbing Alcohol
Quick answers
  • GPI-14 (Medi-Span): 96201020202070
  • RxCUI (RxNorm): 1797913
Why two NDCs? The FDA registers this code as 11822-0443-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 11822-0443-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Injections treat severe allergic conditions, joint inflammation, certain skin problems and eye inflammation. Creams and ointments calm itchy, inflamed sk...
  • Injections are given by a healthcare professional. Ointment is applied as a thin film to the affected area two to three times daily. Nasal spray bottles need priming before first u...
  • Possible effects include injection site pain, joint swelling, headache, muscle spasms, cough, sinusitis and bruising. People with diabetes may see higher blood sugar. Tell your doc...
  • Call right away for signs of an allergic reaction, fever or infection, a very painful and swollen joint, vision changes, or mood changes. Also report black stools, severe stomach p...
📖 Read our full Triamcinolone guide →
8
Nutrient depletion considerations

Triamcinolone Acetonide may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
11822-0443-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE 2017-06-15 Aug 1, 2026 Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Nasal Allergy 55 ug 00113-0443-01 L. 1 bottle $0.739 — Availability likely —
Nasal Allergy 55 ug 00536-1457-69 Rugby 1 bottle $0.739 — Availability likely —
Triamcinolone Acetonide Nasal 55 ug 45802-0109-01 Padagis 1 bottle $0.739 — Availability likely —
Good Neighbor Pharmacy 24 Hour Nasal Allergy 55 ug 46122-0385-76 Amerisource 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 60505-6275-07 Apotex 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 70000-0702-01 CARDINAL 1 bottle $0.739 — Discontinued —
Triamcinolone Acetonide 55 ug 70000-0742-01 CARDINAL 1 bottle $0.739 — Availability likely —
foster and thrive 24 hour nasal allergy 55 ug 70677-1023-01 Strategic 1 bottle $0.739 — Availability likely —
Allergy Nasal 55 ug 00363-0811-01 Walgreen 1 bottle — — FDA listed —
Up and Up Nasal Allergy 55 ug 11673-0717-01 Target 1 bottle — — FDA listed —
Nasal Allergy 55 ugthis 11822-0443-01 Rite 1 bottle — — Discontinued —
Signature Care Nasal Allergy 55 ug 21130-0443-01 Safeway 1 bottle — — FDA listed —
Nasal Allergy 55 ug 21130-0613-02 Safeway 1 bottle — — FDA listed —
Nasal Allergy Relief 55 ug 30142-0665-01 Kroger 1 bottle — — FDA listed —
nasal allergy 55 ug 30142-0813-01 Kroger 1 bottle — — FDA listed —
Topcare Nasal Allergy 55 ug 36800-0621-01 Topco 1 bottle — — FDA listed —
Nasal Allergy 55 ug 37808-0443-01 H 1 bottle — — FDA listed —
Equaline nasal allergy 55 ug 41163-0443-01 United 1 bottle — — FDA listed —
Nasacort Allergy 24HR 55 ug 41167-5800-01 Chattem, 1 bottle — — FDA listed —
24 Hour Nasal Allergy 55 ug 41250-0443-01 Meijer 1 bottle — — FDA listed —
CareOne Allergy Relief 55 ug 41520-0443-01 American 1 bottle — — Discontinued —
Equate Nasal Allergy 55 ug 49035-0443-01 Wal-Mart 1 bottle — — FDA listed —
Nasacort 55 ug 50090-1444-00 A-S 1 bottle — — FDA listed —
allergy relief 55 ug 51316-0711-01 CVS 1 bottle — — FDA listed —
DG Health Nasal Allergy 55 ug 55910-0280-02 Dolgencorp, 1 bottle — — FDA listed —
Nasal Allergy 55 ug 59779-0746-01 CVS 1 bottle — — FDA listed —
Triamcinolone acetonide 55 ug 69168-0482-01 Allegiant 1 bottle — — FDA listed —
Triamcinolone Acetonide Nasal 55 ug 72162-2289-02 Bryant 1 bottle — — FDA listed —
Basic Care Nasal Allergy 55 ug 72288-0443-01 Amazon.com 1 bottle — — FDA listed —
Nasal Allergy 55 ug 42507-0443-01 HyVee 1 bottle — — FDA listed —
Triamcinolone Acetonide 55 ug 58602-0035-07 Aurohealth 1 bottle — — FDA listed —
Childrens Triamcinolone Acetonide 55 ug 58602-0037-11 Aurohealth 1 bottle — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2017
On the market since
Jun 2017
📍
2026
Currently FDA-listed
9 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRite Aid Corporation
Application holderPERRIGO PHARMA INTERNATIONAL DAC
FDA applicationANDA078104 (ANDA)
Labeler code11822
First marketedJun 2017
Product typeHuman Otc Drug
Portfolio326 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 24 words ▾

Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • sneezing • itchy nose

⏱️ Dosage and Administration ~1 min read ▾

Directions Read insert (inside package) on how to: • get a new bottle ready (primed) before first use • prime bottle again if not used for more than 2 weeks • use the spray • clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older • once daily, spray 2 times into each nostril while sniffing gently • once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 2 TO UNDER 12 YEARS OF AGE • the growth rate of some children may be slower while using this product.

Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. children 6 to under 12 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age • an adult should supervise use • once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age • do not use • do not use more than directed • if you forget a dose, do not double the next dose • do not spray into eyes or mouth • if allergy symptoms do not improve after one week, stop using and talk to a doctor • do not use for the common cold • shake well before each use

⚠️ Warnings ~1 min read ▾

Warnings Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 28 words ▾

Other information • do not use if printed bottle wrap is torn or opened • keep package and insert. They contain important information. • store between 20°-25°C (68°-77°F)

🧪 Active Ingredient 10 words ▾

Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)

🧪 Inactive Ingredients 25 words ▾

Inactive ingredients benzalkonium chloride, carboxymethylcellulose sodium, dextrose anhydrous, edetate disodium dihydrate, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

🎯 Purpose 4 words ▾

Purpose Allergy symptom reliever

📄 Do Not Use 25 words ▾

Do not use • in children under 2 years of age • if you have ever had an allergic reaction to any of the ingredients

📄 Ask a Doctor Before Use If 50 words ▾

Ask a doctor before use if you • have had recent nose ulcers or nose surgery • have had a nose injury that has not healed • are using a steroid medicine for asthma, allergies or skin rash • have an eye infection • have or had glaucoma or cataracts

📄 When Using This Product 71 words ▾

When using this product • the growth rate of some children may be slower • some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. • do not share this bottle with anyone else as this may spread germs • remember to tell your doctor about all the medicines you take, including this one

📄 Stop Use and Ask a Doctor If 50 words ▾

Stop use and ask a doctor if • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis • you have or develop symptoms of an infection such as a persistent fever • you have any change in vision • you have severe or frequent nosebleeds

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 76 words ▾

Package/Label Principal Display Panel Compare to the active ingredient of Nasacort ® Allergy 24HR ORIGINAL PRESCRIPTION STRENGTH NASAL ALLERGY SPRAY TRIAMCINOLONE ACETONIDE NASAL SPRAY, 55 mcg PER SPRAY ALLERGY SYMPTOM RELIEVER (GLUCOCORTICOID)* *Triamcinolone acetonide is a steroid medicine known as a glucocorticoid. 24 HOUR RELIEF OF Nasal Congestion – Runny nose Sneezing - Itchy nose alcohol free – scent free – non-drowsy MULTI-SYMPTOM 24 HOUR 120 SPRAYS

0.57FL OZ (16.9 mL) nasal allergy spray image

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide (matched by generic name) — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. CMS lists 5 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Rite Aid Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.